ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Wender Named ACS Chief Cancer Control Officer

August 9, 2013

In Brief: Eyre ACS President, Freeman President Elects, Kathleen Horsch Chairman, Davis Heads ASTRO

November 20, 1987

NIH Considering Longer grant Award Periods; CCIRC’s New Bosses Crack Dow On Conferences

November 10, 1978

NCI to Ask Cancer Panel, NCAB, to Help Respond To Request for Review Of National Cancer Program

December 4, 1992

In Brief: Three Comprehensive Centers Have Problems But Aren’t On “Probation”; Amos On Budget

June 9, 1978

FDA Holds Up Another IND; Rauscher, FDA Commissioner Hold “Excellent” Meeting

March 19, 1976